Abstract:An appropriate conventional method has been utilised to synthesise new tridentate Schiff base ligand 4-chloro-2-((2,4-dihydroxybenzylidene)amino)benzoic acid with Co (II), Ni (II), Cu (II), and Zn (II) complexes. Several spectroscopic(FT-IR, 1 H NMR, 13 C NMR, UV–Vis, Mass), TGA-DTA, powder X-ray diffraction, and DFT calculations, were used to characterise these complexes.According to these spectroscopic investigations, the ligand coordinated with the metals via carboxylic oxygen, azomethine nitrogen, and hydroxyl oxygen, acting as a tridentate ligand. Appropriate geometry for every complex has been proposed based on spectroscopic and analytical data. In tetrahedral geometry with Co(II), Ni(II), Zn(II), and square planner with Cu(II) ion, the ligand functions as a tridentate via ONO donors.The optimal structure (bond length and bond angle) and chemical reactivity of the ligand and its metal complexes from their Frontier Molecular Orbitals (FMO) and Molecular electrostatic potential (MESP) calculations have been investigated using Density Functional Theory (DFT/B3LYP,6-31G**/6-311G**(d,p), and LanL2DZ basis sets) calculations. In vitro DPPH radical scavenging techniques were used to assess the antioxidant activity of the ligand and its metal complexes. The results indicated that all of the complexes exhibited good antioxidant activity, with Cu (II) complex being the most potent with the lowest IC 50 values.The ligand and complexes' in vitro antibacterial activities were further explored by screening them against Gram(+ve) bacteria (Bacillus subtilis) and Gram(−ve) bacteria (E. coli) . Significant activity was demonstrated by all synthesised compounds against the tested strains of bacteria. The antifungal activity of complexes against Aspergillus niger and Candida albicans was determined. The results indicated that Cu (II) complex exhibited good antifungal activity against Candida albicans , but not against Aspergillus niger . The fungal strain Aspergillus niger was not significantly inhibited by complexes. The complexes have greater antimicrobial activity than the Schiff base ligand, as indicated by the MIC values.

A study of mononuclear 3d transition metal bis-Schiff base complexes: Synthesis, characterization, and evaluation of their antibacterial activity

Synthesis, structure elucidation, antioxidant, antimicrobial, anti-inflammatory and molecular docking studies of transition metal(II) complexes derived from heterocyclic Schiff base ligands

Synthesis, Structural and Antimicrobial Studies of Transition Metal Complexes of a Novel Schiff Base Ligand Incorporating 1,2,4-Triazole and 4-(Benzyloxy)benzaldehyde Moieties

Synthesis, spectral studies and antimicrobial evaluation of transition metal complexes of bidentate Schiff base ligands derived from 4-amino quinoline

Synthesis, structural elucidation, molecular modeling and antimicrobial studies of Mn(II), Co(II), Ni(II), and Cu(II) complexes containing NO donor bidentate Schiff base

Synthesis, characterization and antimicrobial study of polymeric transition metal complexes of Mn(II), Co(II), Ni(II), Cu(II) and Zn(II)

Synthesis, DFT, Molecular Docking, and Antimicrobial Studies of New Indole-Thiosemicarbazone Ligand and Their Complexes with Fe(III), Co(II), Ni(II), Cu(II)

Structure elucidation {single X-ray crystal diffraction studies, Hirshfeld surface analysis, DFT} and antibacterial studies of 1,2-benzothiazine metal complexes

Synthesis, spectroscopic characterization, density functional theory calculations and biological evaluation of novel Cu(II) and Zn(II) Schiff base complexes as antimicrobial agents

Synthesis and characterization of novel metal complexes with new azo-schiff base ligand derived from sulfa drug and toxicological studies of its complexes as antibacterial

Synthesis, Characterization, Biological, ADMET, and Molecular Docking Studies of Transition Metal Complexes of Aminopyridine Schiff Base Derivative

Co(II), Ni(II), Cu(II) and Zn(II) complexes of 1,8-naphthalimide-based ligand: syntheses, characterizations and evaluation of antibacterial activities

Synthesis, Spectroscopic, Computational Structure Analysis, Molecular Docking, in vitro Antibacterial and in vivo Antipyretic Investigations of Transition Metal(II) Complexes

Synthesis, spectro-themal characterization, DFT calculations and biochemical evaluation of a newly synthesized tridentate Schiff base transition metal complexes

Nickel(II), copper(II) and zinc(II) complexes containing symmetrical Tetradentate Schiff base ligand derived from 3,5-diiodosalicylaldehyde: Synthesis, characterization, crystal structure and antimicrobial activity

Synthesis, Characterization and in vitro Biological Evaluation of a New Schiff Base Derived from Drug and its Complexes with Transition Metal Ions

Exploration on Synthesis, Characterization and Biological Activities of Transition Metal Complexes Comprising Hydroxybenzylideneaminocyclohexylimino-methyl-4,6-dibromophenol Schiff Base Ligand

Novel Schiff base (E)-2-((4-chloro-3-nitrophenylimino)(phenyl)methyl)-5-methoxyphenol and Mixed Ligand Complexes of Mn(II), Fe(III), Co(II), Ni(II) and Cu(II): synthesis, structure elucidation and potency study as antibacterial, antimalarial, antioxidant, antidibetic and anticancer agents

Synthesis, Characterization, DNA Cleavage, and Antimicrobial Studies of Some Transition Metal Complexes With a Novel Schiff Base Derived From 2-Aminopyrimidine

Manganese(II) and Zinc(II) metal complexes of novel bidentate formamide-based Schiff base ligand: synthesis, structural characterization, antioxidant, antibacterial, and in-silico molecular docking study

Green and Efficient Synthesis, Spectroscopic, Characterization, Antibacterial Activity of Some Selected Transition Metal Complexes of Novel Schiff Base Ligand Derived from 2-amino 5-methyl benzimidazole with 2-bromo Isophthalaldehyde